Revealing the Anti-Cancer Potential of 1,2,3-Triazole-Isonicotinate Derivatives Targeting EGFR Kinase Inhibition in MCF-7 Cancer Cells: Design, Synthesis, Biological Evaluation, and In Silico Studies.

Saved in:
Bibliographic Details
Title: Revealing the Anti-Cancer Potential of 1,2,3-Triazole-Isonicotinate Derivatives Targeting EGFR Kinase Inhibition in MCF-7 Cancer Cells: Design, Synthesis, Biological Evaluation, and In Silico Studies.
Authors: Khalaf Alshamari, Asma1 (AUTHOR) ak.alshamari@uoh.edu.sa, Abdella, Faiza I. A.1 (AUTHOR), Abdullah AlRashidi, Aljazi1 (AUTHOR), Zaheed Alshammari, Mona1 (AUTHOR), Khashman Alshammari, Hissah1 (AUTHOR), S. Alsaif, Nuha Othman1 (AUTHOR), El Malah, Tamer2 (AUTHOR)
Source: Polycyclic Aromatic Compounds. 2025, Vol. 45 Issue 8, p1627-1648. 22p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:10406638
DOI:10.1080/10406638.2025.2490142